Investment
Features
FeesSafety
Academy
More
Pluang+

Cannabix and Omega launch breath test panel detecting recent use of multiple drugs like DOT urine tests.

Market News
08 Jul 2026
GlobeNewsWire
View Source
Bullish
Cannabix and Omega launch breath test panel detecting recent use of multiple drugs like DOT urine tests.

Cannabix Technologies and Omega Laboratories have developed a breath-based drug testing panel that detects recent use of multiple drug classes, modeled after the federally mandated DOT urine drug test panel. This new breath test can identify amphetamines, cocaine, marijuana, opiates, and PCP within minutes to hours after use, offering a more immediate and relevant detection window compared to traditional urine or hair tests. The test uses mass spectrometry for high accuracy and is designed for safety-sensitive environments such as workplaces, courts, and law enforcement. This advancement aims to improve decision-making by focusing on recent drug use rather than historical use, with the breath test currently available to clients and expected to complement existing drug testing methods.

More News

Lamb Weston expects Q3 EPS of $0.59 on stable $1.65B revenue, driven by cost savings and efficiency gains.

Lamb Weston expects Q3 EPS of $0.59 on stable $1.65B revenue, driven by cost savings and efficiency gains.

Lamb Weston is set to report Q3 earnings with analysts forecasting an EPS of $0.59, down from $0.74 last year, and revenue around $1.65 billion, nearly flat compared to the prior year. The company’s "Focus to Win" strategy has generated over $100 mil...

Company Fundamentals
Neutral
1 hour ago
Cal-Maine Foods downgraded to Hold after $58.6M loss and 42% sales drop due to egg price slump

Cal-Maine Foods downgraded to Hold after $58.6M loss and 42% sales drop due to egg price slump

Cal-Maine Foods reported a $58.6 million net loss and a 42% drop in net sales, driven by lower conventional egg prices. An analyst downgraded the stock to Hold with a $70 price target, reflecting a modest 2.85% upside from current levels. Despite cha...

Analyst Insights
Bearish
2 hours ago
PNC Financial sees mixed analyst ratings with price targets near $265-$284 amid solid fundamentals.

PNC Financial sees mixed analyst ratings with price targets near $265-$284 amid solid fundamentals.

PNC Financial Services Group received mixed analyst ratings on October 1, 2026. Evercore ISI maintained an Outperform rating but lowered its price target to $265 from $285, citing strong net interest income growth but caution on expenses and asset qu...

Analyst Insights
Bullish
2 hours ago
Accenture beats earnings estimates, shares jump 17% on strong growth and upbeat 2027 outlook

Accenture beats earnings estimates, shares jump 17% on strong growth and upbeat 2027 outlook

Accenture reported fiscal Q4 2026 earnings that exceeded analyst expectations with EPS of $3.29, up 46% year-over-year, and revenue of $18.68 billion, a 6% increase. The company also saw a 4% rise in new bookings to $22.17 billion, reflecting strong ...

Company Fundamentals
Bullish
2 hours ago
Analysts lower PepsiCo targets amid sales struggles and dividend concerns.

Analysts lower PepsiCo targets amid sales struggles and dividend concerns.

Analysts have downgraded PepsiCo and lowered its price targets due to weak stock performance and sales challenges in its Frito-Lay North America segment. Despite efforts to improve products, sales remain sluggish, raising concerns about PepsiCo's ope...

Analyst Insights
Bearish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App